Archive - February 2019
Cablivi gets FDA OK for blood clotting disorder
GSK posts Q4 profit
Zogenix submits new drug application to FDA for Fintepla
Sanofi extends growth spurt thanks to Genzyme, Dupixent
Roche to treat 1,500 hemophilia A patients in developing countries
Galapagos expands presence in fibrosis, NASH with Evotec deal
Fasenra granted Orphan Drug Designation by FDA
Mundipharma launches Pelmeg biosimilar in Europe